Scientists test new mental health drug's safety with common treatments
NCT ID NCT06729970
Summary
This early-stage study tested how a new schizophrenia drug called KarXT interacts with three common mood medications (lithium, valproic acid, and lamotrigine). Researchers gave healthy volunteers different combinations of these drugs to see how they affect each other in the body. The main goal was to understand potential drug interactions and safety before testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Los Alamitos, California, 90720-3115, United States
Conditions
Explore the condition pages connected to this study.